Texas · 89th Legislature (2025) · Bill

HB 3057: Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Enacted Last action June 20, 2025: Effective on 9/1/25

Plain-language summary

HB 3057 is a bill introduced in the Texas House on February 19, 2025. According to its official title, it concerns: Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy. Primary sponsor: Brooks Landgraf (Republican), Kevin Sparks (Republican). It lists 1 additional sponsor. Most recent recorded action (June 20, 2025): Effective on 9/1/25.

Sponsors

Primary sponsors: Brooks Landgraf (Republican); Kevin Sparks (Republican). 1 co-sponsor.